Literature DB >> 32199103

Alzheimer's Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways.

Na Zhao1, Yingxue Ren2, Yu Yamazaki3, Wenhui Qiao3, Fuyao Li3, Lindsey M Felton3, Siamak Mahmoudiandehkordi4, Alexandra Kueider-Paisley4, Berkiye Sonoustoun3, Matthias Arnold5, Francis Shue6, Jiaying Zheng6, Olivia N Attrebi3, Yuka A Martens3, Zonghua Li3, Ligia Bastea7, Axel D Meneses3, Kai Chen3, J Will Thompson8, Lisa St John-Williams9, Masaya Tachibana3, Tomonori Aikawa3, Hiroshi Oue3, Lucy Job3, Akari Yamazaki3, Chia-Chen Liu3, Peter Storz7, Yan W Asmann2, Nilüfer Ertekin-Taner10, Takahisa Kanekiyo3, Rima Kaddurah-Daouk4, Guojun Bu11.   

Abstract

Evidence suggests interplay among the three major risk factors for Alzheimer's disease (AD): age, APOE genotype, and sex. Here, we present comprehensive datasets and analyses of brain transcriptomes and blood metabolomes from human apoE2-, apoE3-, and apoE4-targeted replacement mice across young, middle, and old ages with both sexes. We found that age had the greatest impact on brain transcriptomes highlighted by an immune module led by Trem2 and Tyrobp, whereas APOE4 was associated with upregulation of multiple Serpina3 genes. Importantly, these networks and gene expression changes were mostly conserved in human brains. Finally, we observed a significant interaction between age, APOE genotype, and sex on unfolded protein response pathway. In the periphery, APOE2 drove distinct blood metabolome profile highlighted by the upregulation of lipid metabolites. Our work identifies unique and interactive molecular pathways underlying AD risk factors providing valuable resources for discovery and validation research in model systems and humans.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOE; Alzheimer’s disease; Serpina3; age; extracellular vesicles; inflammation; lipid metabolism; metabolomics; sex; transcriptomics

Mesh:

Substances:

Year:  2020        PMID: 32199103      PMCID: PMC7388065          DOI: 10.1016/j.neuron.2020.02.034

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   18.688


  98 in total

1.  Alpha 1-antichymotrypsin inhibits A beta degradation in vitro and in vivo.

Authors:  C R Abraham; W T McGraw; F Slot; R Yamin
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  RSeQC: quality control of RNA-seq experiments.

Authors:  Liguo Wang; Shengqin Wang; Wei Li
Journal:  Bioinformatics       Date:  2012-06-27       Impact factor: 6.937

3.  Plasma phospholipids identify antecedent memory impairment in older adults.

Authors:  Mark Mapstone; Amrita K Cheema; Massimo S Fiandaca; Xiaogang Zhong; Timothy R Mhyre; Linda H MacArthur; William J Hall; Susan G Fisher; Derick R Peterson; James M Haley; Michael D Nazar; Steven A Rich; Dan J Berlau; Carrie B Peltz; Ming T Tan; Claudia H Kawas; Howard J Federoff
Journal:  Nat Med       Date:  2014-03-09       Impact factor: 53.440

4.  A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.

Authors:  Hadas Keren-Shaul; Amit Spinrad; Assaf Weiner; Orit Matcovitch-Natan; Raz Dvir-Szternfeld; Tyler K Ulland; Eyal David; Kuti Baruch; David Lara-Astaiso; Beata Toth; Shalev Itzkovitz; Marco Colonna; Michal Schwartz; Ido Amit
Journal:  Cell       Date:  2017-06-08       Impact factor: 41.582

5.  Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

Authors:  Liesi E Hebert; Jennifer Weuve; Paul A Scherr; Denis A Evans
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

6.  Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.

Authors:  C R Abraham; D J Selkoe; H Potter
Journal:  Cell       Date:  1988-02-26       Impact factor: 41.582

7.  ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.

Authors:  Yang Shi; Kaoru Yamada; Shane Antony Liddelow; Scott T Smith; Lingzhi Zhao; Wenjie Luo; Richard M Tsai; Salvatore Spina; Lea T Grinberg; Julio C Rojas; Gilbert Gallardo; Kairuo Wang; Joseph Roh; Grace Robinson; Mary Beth Finn; Hong Jiang; Patrick M Sullivan; Caroline Baufeld; Michael W Wood; Courtney Sutphen; Lena McCue; Chengjie Xiong; Jorge L Del-Aguila; John C Morris; Carlos Cruchaga; Anne M Fagan; Bruce L Miller; Adam L Boxer; William W Seeley; Oleg Butovsky; Ben A Barres; Steven M Paul; David M Holtzman
Journal:  Nature       Date:  2017-09-20       Impact factor: 69.504

8.  Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles.

Authors:  Mohashin Pathan; Pamali Fonseka; Sai V Chitti; Taeyoung Kang; Rahul Sanwlani; Jan Van Deun; An Hendrix; Suresh Mathivanan
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

9.  WGCNA: an R package for weighted correlation network analysis.

Authors:  Peter Langfelder; Steve Horvath
Journal:  BMC Bioinformatics       Date:  2008-12-29       Impact factor: 3.169

Review 10.  Aging and Alzheimer's disease: Comparison and associations from molecular to system level.

Authors:  Xian Xia; Quanlong Jiang; Joseph McDermott; Jing-Dong J Han
Journal:  Aging Cell       Date:  2018-07-02       Impact factor: 9.304

View more
  51 in total

1.  Cholesterol and matrisome pathways dysregulated in astrocytes and microglia.

Authors:  Julia Tcw; Lu Qian; Nina H Pipalia; Michael J Chao; Shuang A Liang; Yang Shi; Bharat R Jain; Sarah E Bertelsen; Manav Kapoor; Edoardo Marcora; Elizabeth Sikora; Elizabeth J Andrews; Alessandra C Martini; Celeste M Karch; Elizabeth Head; David M Holtzman; Bin Zhang; Minghui Wang; Frederick R Maxfield; Wayne W Poon; Alison M Goate
Journal:  Cell       Date:  2022-06-23       Impact factor: 66.850

2.  P. edulis Extract Protects Against Amyloid-β Toxicity in Alzheimer's Disease Models Through Maintenance of Mitochondrial Homeostasis via the FOXO3/DAF-16 Pathway.

Authors:  Shu-Qin Cao; Yahyah Aman; Evandro F Fang; Tewin Tencomnao
Journal:  Mol Neurobiol       Date:  2022-06-23       Impact factor: 5.682

3.  Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer's disease.

Authors:  Alice Taubes; Phil Nova; Kelly A Zalocusky; Idit Kosti; Mesude Bicak; Misha Y Zilberter; Yanxia Hao; Seo Yeon Yoon; Tomiko Oskotsky; Silvia Pineda; Bin Chen; Emily A Aery Jones; Krishna Choudhary; Brian Grone; Maureen E Balestra; Fayzan Chaudhry; Ishan Paranjpe; Jessica De Freitas; Nicole Koutsodendris; Nuo Chen; Celine Wang; William Chang; Alice An; Benjamin S Glicksberg; Marina Sirota; Yadong Huang
Journal:  Nat Aging       Date:  2021-10-11

4.  Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer's disease.

Authors:  Alberto Serrano-Pozo; Zhaozhi Li; Ayush Noori; Huong N Nguyen; Aziz Mezlini; Liang Li; Eloise Hudry; Rosemary J Jackson; Bradley T Hyman; Sudeshna Das
Journal:  Nat Aging       Date:  2021-10-11

Review 5.  APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Authors:  Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg
Journal:  Mol Neurodegener       Date:  2022-09-24       Impact factor: 18.879

6.  Nonobese Male Patients with Alzheimer's Disease Are Vulnerable to Decrease in Plasma Leptin.

Authors:  Jing Tian; Tienju Wang; Kun Jia; Lan Guo; Russell H Swerdlow; Heng Du
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

7.  Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4.

Authors:  Shaowei Wang; Boyang Li; Victoria Solomon; Alfred Fonteh; Stanley I Rapoport; David A Bennett; Zoe Arvanitakis; Helena C Chui; Patrick M Sullivan; Hussein N Yassine
Journal:  Mol Neurodegener       Date:  2022-06-15       Impact factor: 18.879

Review 8.  Alzheimer's pathogenic mechanisms and underlying sex difference.

Authors:  Donghui Zhu; Axel Montagne; Zhen Zhao
Journal:  Cell Mol Life Sci       Date:  2021-04-12       Impact factor: 9.261

9.  The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer's disease.

Authors:  So-Hee Park; Eun-Hye Lee; Hyung-Ji Kim; Sungyang Jo; Sunju Lee; Sang Won Seo; Hyun-Hee Park; Seong-Ho Koh; Jae-Hong Lee
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

10.  Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease.

Authors:  Young Won Kim; Ismael Al-Ramahi; Amanda Koire; Stephen J Wilson; Daniel M Konecki; Samantha Mota; Shirin Soleimani; Juan Botas; Olivier Lichtarge
Journal:  Alzheimers Dement       Date:  2020-12-07       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.